| Odanacatib | IC50 | 0.2 [1] |
| Odanacatib | Ki | 0.18 [1] |
| 3-(Benzyloxycarbonylamino)pyrrolidine-1-carbonitrile | IC50 | 50.0 [1] |
| 3-(Benzyloxycarbonylamino)pyrrolidine-1-carbonitrile | Ki | 140.0 [1] |
| Pyrrolidine-1-carbonitrile | IC50 | 2100.0 [1] |
| Pyrrolidine-1-carbonitrile | Ki | 2100.0 [1] |
| 1,3-Dihydro-pyrrolo[3,4-b]quinoline-2-carbonitrile | IC50 | 360.0 [1] |
| 1,3-Dihydro-pyrrolo[3,4-b]quinoline-2-carbonitrile | Ki | 380.0 [1] |
| L-873724 | IC50 | 0.2 [1] |
| Balicatib | IC50 | 0.6 [1], 1.4 [2], 5.0 [3] |
| Balicatib | Ki | 1.4 [1] |
| N-[(2S)-4-Methyl-1-oxo-1-[[(4S)-3-oxo-1-pyridin-2-ylsulfonylazepan-4-yl]amino]pentan-2-yl]-1-benzofuran-2-carboxamide | IC50 | 70.0 [1], 80.0 [2] |
| N-[(2S)-4-Methyl-1-oxo-1-[[(4S)-3-oxo-1-pyridin-2-ylsulfonylazepan-4-yl]amino]pentan-2-yl]-1-benzofuran-2-carboxamide | Ki | 0.16 [1] |
| 3-[(Cyclohexylcarbonylamino)methyl]azetidine-1-carbonitrile | IC50 | 16.0 [1] |
| 4-Propyl-6-(3-(trifluoromethyl)phenyl)pyrimidine-2-carbonitrile | IC50 | 33.0 [1] |
| (S)-Tert-butyl 1-oxohexan-2-ylcarbamate | IC50 | 51.0 [1] |
| Benzyl N-[(2S)-4-methyl-1-[3-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-4-oxopyrrolidin-1-yl]-1-oxopentan-2-yl]carbamate | Ki | 2.0 [1], 2.3 [2] |
| (2R)-N-(Cyanomethyl)-4-methyl-2-[3-(4-piperazin-1-ylphenyl)phenyl]pentanamide | IC50 | 3.0 [1], 7.8 [2], 11.0 [3] |
| (2R)-N-(Cyanomethyl)-4-methyl-2-[3-(4-piperazin-1-ylphenyl)phenyl]pentanamide | Ki | 8.0 [1] |
| N-(1-Cyanopyrrolidin-3-yl)benzenesulfonamide | IC50 | 18.0 [1], 50.0 [2], 81.0 [3], 750.0 [4] |
| N-(1-Cyanopyrrolidin-3-yl)benzenesulfonamide | Ki | 90.0 [1] |
| Azetidine-1-carbonitrile | IC50 | 100.0 [1], 450.0 [2], 480.0 [3], 880.0 [4], 100000.0 [5] |
| 2,4-Dimethylpentan-3-yl N-[(3S)-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]heptan-3-yl]carbamate | IC50 | 2.5 [1], 2.51 [2], 2.54 [3], 2500.0 [4] |
| N-[(2S)-1-[2-(4-Methoxyanilino)ethylamino]-4-methyl-1-oxopentan-2-yl]-3-methylbenzamide | IC50 | 372.0 [1] |
| N-[(2S)-1-[2-(4-Methoxyanilino)ethylamino]-4-methyl-1-oxopentan-2-yl]-3-methylbenzamide | Ki | 43.0 [1], 91.0 [2] |
| (S)-1-Cyclohexylpropan-2-yl (S)-1-oxohexan-2-ylcarbamate | IC50 | 2.7 [1] |
| 1,3-Bis[[n-[(phenylmethoxy)carbonyl]-l-leucyl]amino]-2-propanone | Ki | 22.0 [1] |
| N-[(2S)-4-Methyl-1-oxo-1-[[(4S)-3-oxo-1-[2-(3-pyridin-2-ylphenyl)acetyl]azepan-4-yl]amino]pentan-2-yl]-5-(2-morpholin-4-ylethoxy)-1-benzofuran-2-carboxamide | IC50 | 30.0 [1] |
| N-[(2S)-4-Methyl-1-oxo-1-[[(4S)-3-oxo-1-[2-(3-pyridin-2-ylphenyl)acetyl]azepan-4-yl]amino]pentan-2-yl]-5-(2-morpholin-4-ylethoxy)-1-benzofuran-2-carboxamide | Ki | 0.0 [1], 0.1 [2] |
| Relacatib | IC50 | 0.5 [1] |
| Relacatib | Ki | 0.04 [1] |
| (2S)-N-(Cyanomethyl)-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-piperazin-1-ylphenyl)phenyl]ethyl]amino]pentanamide | IC50 | 0.01 [1] |
| [(2S)-3,3-Dimethyl-1-[3-[4-(trifluoromethyl)phenyl]pyrazol-1-yl]butan-2-yl] N-[(3S)-1,2-dioxo-1-(1H-pyrazol-5-ylamino)heptan-3-yl]carbamate | IC50 | 0.07 [1], 72.0 [2] |
| {1-[2-(4-Methoxy-phenylamino)-ethylcarbamoyl]-3-methyl-butyl}-carbamic acid benzyl ester | IC50 | 60.0 [1], 70.0 [2], 90.0 [3] |
| Benzyl N-[(2S)-1-[[(2S)-4-methoxy-3-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamate | Ki | 60.0 [1] |
| [(3R)-4,4-Dimethyl-1-phenylpentan-3-yl] N-[(3S)-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]heptan-3-yl]carbamate | IC50 | 1.1 [1] |
| Tert-butyl N-[(3S)-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]heptan-3-yl]carbamate | IC50 | 1200.0 [1], 1202.26 [2] |
| Benzyl N-[(2S)-4-methyl-1-[2-[2-[(1S)-3-methyl-1-(phenylmethoxycarbonylamino)butyl]-1,3-thiazole-4-carbonyl]hydrazinyl]-1-oxopentan-2-yl]carbamate | Ki | 10.0 [1] |
| (1r,2r)-N-(1-Cyanocyclopropyl)-2-{[4-(4-Fluorophenyl)piperazin-1-Yl]carbonyl}cyclohexanecarboxamide | IC50 | 15.0 [1], 15.85 [2] |
| N-[(2S)-1-[2-(4-Methoxyanilino)ethylamino]-4-methyl-1-oxopentan-2-yl]-4-phenylmethoxybenzamide | IC50 | 3.0 [1], 6.0 [2] |
| N-[(2S)-1-[2-(4-Methoxyanilino)ethylamino]-4-methyl-1-oxopentan-2-yl]-4-phenylmethoxybenzamide | Ki | 15.0 [1] |
| 1-(2,3-Dichlorophenyl)-N-[(2S)-1-[2-(4-methoxyanilino)ethylamino]-4-methyl-1-oxopentan-2-yl]-1,2,4-triazole-3-carboxamide | IC50 | 3.0 [1], 9.0 [2] |
| 1-(2,3-Dichlorophenyl)-N-[(2S)-1-[2-(4-methoxyanilino)ethylamino]-4-methyl-1-oxopentan-2-yl]-1,2,4-triazole-3-carboxamide | Ki | 11.0 [1] |
| 3-[(Phenylsulfonylamino)methyl]azetidine-1-carbonitrile | IC50 | 17.0 [1], 20.0 [2] |
| 3-[(Phenylsulfonylamino)methyl]azetidine-1-carbonitrile | Ki | 20.0 [1] |
| N-[(2S)-1-[(3As,6R,6aR)-6-ethynyl-3-oxo-3a,5,6,6a-tetrahydrofuro[3,2-b]pyrrol-4-yl]-4-methyl-1-oxopentan-2-yl]-4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]benzamide | Ki | 1.6 [1], 50.0 [2] |
| N-[(2S)-1-[(3As,6R,6aR)-6-ethynyl-3-oxo-3a,5,6,6a-tetrahydrofuro[3,2-b]pyrrol-4-yl]-4-methyl-1-oxopentan-2-yl]-4-[5-fluoro-2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]benzamide | Ki | 1.1 [1], 50.0 [2] |
| Calpeptin | IC50 | 0.11 [1] |
| N-(1-((Cyanomethyl)carbamoyl)cyclohexyl)-4-(2-(4-methylpiperazin-1-yl)thiazol-4-yl)benzamide | IC50 | 0.25 [1], 0.6 [2] |
| Morpholine-4-carboxylic acid (1-(3-benzenesulfonyl-1-phenethylallylcarbamoyl)-3-methylbutyl)-amide | IC50 | 4.0 [1], 6.2 [2] |
| Grassystatin A | IC50 | 10000.0 [1] |
| Cathepsin inhibitor 1 | IC50 | 3162.28 [1] |
| 7-(2,2-Dimethylpropyl)-6-[(1,3-dioxo-2,8-diazaspiro[4.5]decan-2-yl)methyl]pyrrolo[2,3-d]pyrimidine-2-carbonitrile | IC50 | 1.0 [1] |
| N-[1-(Cyanomethylcarbamoyl)cyclohexyl]-4-(4-piperazin-1-ylphenyl)benzamide | IC50 | 0.4 [1] |
| N-[(2S)-3-Cyclohexyl-1-[2-(4-methoxyanilino)ethylamino]-1-oxopropan-2-yl]-5-[3-(trifluoromethyl)phenyl]furan-2-carboxamide | Ki | 65000.0 [1] |
| (2S)-N-[(1S)-1-Cyano-2-phenylethyl]-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfonylphenyl)phenyl]ethyl]amino]pentanamide | IC50 | 0.6 [1] |
| (1R,2R)-N-(1-Cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexane-1-carboxamide | IC50 | 1.0 [1] |
| 5-Tert-butyl-N-[(2S)-1-(cyanomethylamino)-3-(3-methylphenyl)-1-oxopropan-2-yl]-2-methylpyrazole-3-carboxamide | IC50 | 2511.89 [1] |
| (2S)-1-Phenylpropan-2-yl [(2S)-1-oxohexan-2-yl]carbamate | IC50 | 1.8 [1] |
| [(3S)-4,4-Dimethyl-2-oxooxolan-3-yl] N-[(3S)-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]heptan-3-yl]carbamate | IC50 | 3.0 [1] |
| (2S)-N-(Cyanomethyl)-4-methyl-2-[[4-(4-piperazin-1-ylphenyl)thiophen-3-yl]amino]pentanamide | IC50 | 0.2 [1], 1.0 [2] |
| (1R)-2-Methyl-1-(phenylmethyl)propyl[(1S)-1-formylpentyl]carbamate | IC50 | 0.5 [1] |
| 1-(Phenylmethyl)cyclopentyl[(1S)-1-formylpentyl]carbamate | IC50 | 0.35 [1] |
| [(2R)-1-[5-(4-Fluorophenyl)-1,3,4-oxadiazol-2-yl]-3,3-dimethylbutan-2-yl] N-[(3S)-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]heptan-3-yl]carbamate | IC50 | 0.37 [1], 370.0 [2] |
| (1-Benzylcyclobutyl)methyl N-[(3S)-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]heptan-3-yl]carbamate | IC50 | 8.5 [1], 8.51 [2] |
| N-[1-[[(2S)-1-Oxo-1-(5-phenyl-1,3,4-oxadiazol-2-yl)pentan-2-yl]carbamoyl]cyclohexyl]-4-(trifluoromethoxy)benzamide | Ki | 29.0 [1] |
| N-[1-[[(2S)-1-(5-Ethyl-1,3,4-oxadiazol-2-yl)-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-4-(trifluoromethoxy)benzamide | Ki | 7.9 [1] |
| [(2R)-3,3-Dimethyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)butan-2-yl] N-[(3S)-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]heptan-3-yl]carbamate | IC50 | 0.24 [1], 240.0 [2] |
| [(2S)-3,3-Dimethyl-1-[4-[4-(trifluoromethyl)phenyl]pyrazol-1-yl]butan-2-yl] N-[(3S)-1,2-dioxo-1-(1H-pyrazol-5-ylamino)heptan-3-yl]carbamate | IC50 | 0.03 [1], 32.0 [2] |
| N-[1-[[(2S)-1-[5-(4-Methoxyphenyl)-1,3,4-oxadiazol-2-yl]-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-4-(trifluoromethoxy)benzamide | Ki | 22.0 [1] |
| [1-(3-Phenylpropyl)cyclobutyl]methyl N-[(3S)-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]heptan-3-yl]carbamate | IC50 | 16.98 [1], 17.0 [2] |
| [(2S)-3,3-Dimethyl-1-[4-[4-(trifluoromethyl)phenyl]imidazol-1-yl]butan-2-yl] N-[(3S)-1,2-dioxo-1-(1H-pyrazol-5-ylamino)heptan-3-yl]carbamate | IC50 | 0.03 [1], 26.0 [2] |
| [(2R)-3,3-Dimethyl-1-[5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]butan-2-yl] N-[(3S)-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]heptan-3-yl]carbamate | IC50 | 0.41 [1], 410.0 [2] |
| N-[1-[[(2S)-1-Oxo-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]pentan-2-yl]carbamoyl]cyclohexyl]-4-(trifluoromethoxy)benzamide | Ki | 54.0 [1] |
| [(2S)-3,3-Dimethyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)butan-2-yl] N-[(3S)-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]heptan-3-yl]carbamate | IC50 | 457.09 [1], 460000.0 [2] |
| [(2R)-3,3-Dimethyl-1-[5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]butan-2-yl] N-[(3S)-1,2-dioxo-1-(1H-pyrazol-5-ylamino)heptan-3-yl]carbamate | IC50 | 0.03 [1], 29.0 [2] |
| [1-(2-Phenylethyl)cyclobutyl]methyl N-[(3S)-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]heptan-3-yl]carbamate | IC50 | 23.99 [1], 24.0 [2] |
| [(2S)-3,3-Dimethyl-1-[4-[4-(trifluoromethyl)phenyl]imidazol-1-yl]butan-2-yl] N-[(3S)-1,2-dioxo-1-(1,3-thiazol-2-ylamino)heptan-3-yl]carbamate | IC50 | 5.75 [1], 5800.0 [2] |
| Benzyl N-[(2S)-4-methyl-1-oxo-1-[[3-oxo-1-(4-phenoxyphenyl)sulfonylpiperidin-4-yl]amino]pentan-2-yl]carbamate | Ki | 0.5 [1] |
| N-[(2S)-4-Methyl-1-oxo-1-[(4-oxooxolan-3-yl)amino]pentan-2-yl]quinoline-2-carboxamide | Ki | 44.0 [1] |
| Benzyl N-[(1S)-3-methyl-1-[(4-oxooxolan-3-yl)carbamoyl]butyl]carbamate | Ki | 140.0 [1] |
| N-[(2S)-4-Methyl-1-oxo-1-[[(2S)-3-oxo-4-(pyridin-2-ylsulfonylamino)butan-2-yl]amino]pentan-2-yl]-1-benzofuran-2-carboxamide | IC50 | 7.5 [1] |
| N-[(2S)-4-Methyl-1-oxo-1-[[(2S)-3-oxo-4-(pyridin-2-ylsulfonylamino)butan-2-yl]amino]pentan-2-yl]-1-benzofuran-2-carboxamide | Ki | 7.5 [1] |
| Benzyl N-[(2S)-4-methyl-1-[4-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-3-oxopiperidin-1-yl]-1-oxopentan-2-yl]carbamate | Ki | 2.6 [1] |
| N-[(2S)-4-Methyl-1-oxo-1-[[(4R)-3-oxo-1-pyridin-2-ylsulfonylazepan-4-yl]amino]pentan-2-yl]-1-benzofuran-2-carboxamide | Ki | 0.16 [1], 980.0 [2] |
| 4-Methoxy-N-{1-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-3-methyl-butyl}-benzamide | IC50 | 9.0 [1], 14.0 [2] |
| N-[(2S)-1-[(3Ar,6aS)-4-benzoyl-6-oxo-3,3a,5,6a-tetrahydro-2H-pyrrolo[3,2-b]pyrrol-1-yl]-4-methyl-1-oxopentan-2-yl]-4-tert-butylbenzamide | Ki | 10.1 [1] |
| (2S)-N-(1-Cyanocyclopropyl)-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfonylphenyl)phenyl]ethyl]amino]pentanamide | IC50 | 0.3 [1] |
| N-(Cyanomethyl)-5,5-difluoro-2-[2-(4-methylsulfanylphenyl)phenyl]cyclohexane-1-carboxamide | IC50 | 0.46 [1], 0.5 [2] |
| 4-(3-Piperidin-1-Ylpropyl)-6-[3-(Trifluoromethyl)phenyl]pyrimidine-2-Carbonitrile | IC50 | 4.0 [1] |
| Ethyl 2-((S)-2-(((S)-1-cyclohexylpropan-2-yloxy)carbonyl)hexanoyl)thiazole-4-carboxylate | IC50 | 230.0 [1] |
| 4-Cycloheptyl-6-(3-Piperidin-1-Ylpropyl)pyrimidine-2-Carbonitrile | IC50 | 100.0 [1] |
| N-[(2S)-3-Naphthalen-2-yl-1-oxo-1-[[(4S)-3-oxo-1-pyridin-2-ylsulfonylazepan-4-yl]amino]propan-2-yl]naphthalene-1-carboxamide | Ki | 10000.0 [1] |
| 4-(3-(Pentan-3-ylamino)propyl)-6-(3-(trifluoromethyl)phenyl)pyrimidine-2-carbonitrile | IC50 | 4.0 [1] |
| N-[1-[[(2S)-1-[5-(Furan-2-yl)-1,3,4-oxadiazol-2-yl]-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-4-(trifluoromethoxy)benzamide | Ki | 1.7 [1] |
| CID 16108900 | IC50 | 0.01 [1], 10.0 [2] |
| N-[(2S)-4-Methyl-1-oxo-1-[(3-oxooxan-4-yl)amino]pentan-2-yl]-1-benzothiophene-2-carboxamide | Ki | 8.0 [1], 11.0 [2] |
| 6-[[4-(4-Acetylpiperazin-1-yl)phenoxy]methyl]-7-(2-cyclohexylethyl)pyrrolo[2,3-d]pyrimidine-2-carbonitrile | IC50 | 1500.0 [1], 1650.0 [2] |
| 6-[4-[3-(4-Ethylpiperazin-1-yl)propoxy]-3-(trifluoromethyl)phenyl]-1-methylimidazo[4,5-c]pyridine-4-carbonitrile | IC50 | 331.0 [1] |
| 5-Amino-4-(isobutylamino)-6-morpholinopyrimidine-2-carbonitrile | IC50 | 18.0 [1] |